BaWang International (Group) Holding Limited (HK:1338)
:1338
Want to see HK:1338 full AI Analyst Report?
Top Page
BaWang International (Group) Holding Limited
(1338)
Select Model
Select Model
Rating:52Neutral
Price Target:
HK$0.03
▼(-27.50% Downside)
Action:ReiteratedDate:04/28/26
The score is primarily constrained by weakening profitability and a sharp 2025 free-cash-flow decline despite stable revenue and gross margins. Technicals add further pressure with the stock trading below major moving averages and negative MACD. Valuation is only middling because a ~27 P/E is difficult to justify given the recent earnings deterioration and no dividend yield data.
Positive Factors
Stable revenue & gross margin
Consistent mid-single-digit revenue growth with a sustained ~50% gross margin signals durable product economics and pricing power in core hair-care lines. This supports mid-term profitability resilience and gives management room to invest in marketing or product development without immediate margin pressure.
Negative Factors
Profitability erosion
Sharp decline in net margin and near-zero operating profit indicate weakened earnings power and deteriorating operating leverage. If persistent, this reduces free cash generation and reinvestment capacity, undermining long-term competitiveness and making recovery dependent on structural cost or mix improvements.
Read all positive and negative factors
Positive Factors
Negative Factors
Stable revenue & gross margin
Consistent mid-single-digit revenue growth with a sustained ~50% gross margin signals durable product economics and pricing power in core hair-care lines. This supports mid-term profitability resilience and gives management room to invest in marketing or product development without immediate margin pressure.
Read all positive factors
BaWang International (Group) Holding Limited (1338) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$88.55M
Dividend YieldN/A
Average Volume (3M)1.53M
Price to Earnings (P/E)27.0
Beta (1Y)0.55
Revenue Growth8.10%
EPS Growth-36.36%
CountryHK
Employees255
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)<0.01
Shares Outstanding3,162,440,700
10 Day Avg. Volume2,016,000
30 Day Avg. Volume1,532,333
Financial Highlights & Ratios
PEG Ratio-0.63
Price to Book (P/B)0.68
Price to Sales (P/S)0.38
P/FCF Ratio46.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BaWang International (Group) Holding Limited Business Overview & Revenue Model
Company Description
BaWang International (Group) Holding Limited, together with its subsidiaries, designs, manufactures, trades in, and distributes Chinese herbal products in the People's Republic of China, Hong Kong, Thailand, and Malaysia. It operates through Hair-...
How the Company Makes Money
BaWang International primarily makes money by selling branded personal care products, with revenue recognized from the sale of finished goods (especially hair-care products such as shampoo) to customers. Its core revenue stream is product sales un...
BaWang International (Group) Holding Limited Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
78
Positive
Cash Flow
49
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 266.03M | 252.95M | 237.65M | 246.34M | 273.60M |
| Gross Profit | 135.26M | 128.78M | 119.72M | 92.52M | 99.03M |
| EBITDA | 15.54M | 14.25M | 31.50M | 15.19M | 25.01M |
| Net Income | 3.78M | 6.55M | 13.63M | -19.32M | -9.08M |
Balance Sheet | |||||
| Total Assets | 226.53M | 235.43M | 230.33M | 244.23M | 295.58M |
| Cash, Cash Equivalents and Short-Term Investments | 115.60M | 120.32M | 88.27M | 74.40M | 63.27M |
| Total Debt | 4.42M | 15.89M | 25.10M | 33.28M | 53.45M |
| Total Liabilities | 76.97M | 89.97M | 90.83M | 118.21M | 149.72M |
| Stockholders Equity | 149.56M | 145.47M | 139.50M | 126.02M | 145.85M |
Cash Flow | |||||
| Free Cash Flow | 2.21M | 12.19M | 1.78M | 22.15M | -65.00K |
| Operating Cash Flow | 19.12M | 31.15M | 4.05M | 24.11M | 1.60M |
| Investing Cash Flow | -60.71M | 11.67M | 19.35M | -177.00K | -50.52M |
| Financing Cash Flow | -7.06M | -10.16M | -9.07M | -11.28M | -11.44M |
BaWang International (Group) Holding Limited Technical Analysis
Negative
0.04
Price Trends
0.04
Negative
0.04
Negative
0.04
Negative
Market Momentum
>-0.01
Positive
0.01
Positive
65.28
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1338, the sentiment is Negative. The current price of 0.04 is above the 20-day moving average (MA) of 0.03, above the 50-day MA of 0.04, and below the 200-day MA of 0.04, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 0.01 is Positive, neither overbought nor oversold. The STOCH value of 65.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1338.
BaWang International (Group) Holding Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$289.30M | 9.71 | 3.92% | 10.32% | 2.75% | -21.60% | |
71 Outperform | HK$116.00M | 1.71 | 2.37% | ― | 2.93% | 253.13% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | HK$392.07M | 8.80 | 5.83% | ― | 3.51% | -28.79% | |
52 Neutral | HK$88.55M | 27.02 | 2.58% | ― | 8.10% | -36.36% | |
48 Neutral | HK$951.00M | 92.72 | -12.38% | ― | 52.36% | ― | |
39 Underperform | HK$153.94M | -5.88 | -27.00% | ― | 10.42% | 11.14% |
* Consumer Defensive Sector Average
HK:1338
BaWang International (Group) Holding Limited
0.03
-0.03
-47.27%
HK:0157
Natural Beauty Bio-Technology
0.48
0.00
0.00%
HK:1962
Evergreen Products Group Ltd.
0.46
<0.01
0.22%
HK:3332
Nanjing Sinolife United Co., Ltd. Class H
0.23
-0.22
-48.22%
HK:6893
Hin Sang Group (International) Holding Co. Ltd.
0.10
-0.08
-45.00%
HK:8281
China Golden Classic Group Ltd.
0.13
0.07
116.67%
BaWang International (Group) Holding Limited Corporate Events
BaWang International Delays Dispatch of Circular on Major Connected Transaction
Apr 24, 2026
BaWang International (Group) Holding Limited, a Hong Kong-listed consumer products company best known for its BaWang-branded personal care lines in Greater China, operates primarily through mass-market retail and distribution channels. The group&#...
BaWang International Sets 2026 AGM to Approve Accounts, Board Changes and Share Mandate
Apr 23, 2026
BaWang International (Group) Holding Limited has called its annual general meeting for 28 May 2026 in Guangzhou to present the audited financial statements for the year ended 31 December 2025 and the accompanying directors’ and auditors̵...
BaWang International Seeks Shareholder Approval for Major Related-Party Lease in Guangzhou
Apr 10, 2026
BaWang International has entered into a new five-year lease for production facilities, offices, warehouses and staff dormitories at its Bawang Industrial Complex in Guangzhou, covering 37,997.7 square metres from July 2026 to June 2031. Under IFRS...
BaWang International Clarifies Share Transfer Deadline for 2026 AGM
Mar 27, 2026
BaWang International (Group) Holding Limited has issued a clarification regarding its recently announced annual results for the year ended 31 December 2025. The clarification focuses on administrative details around shareholder eligibility to atte...
BaWang Sets March Board Meeting to Approve 2025 Results and Consider Final Dividend
Mar 11, 2026
BaWang International (Group) Holding Limited has scheduled a board meeting for 26 March 2026 to review and approve the audited final results for the financial year ended 31 December 2025. The board will also consider whether to declare a final div...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.